Scheibenbogen C - Search Results

1

Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.

Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, Christoph F, Miller K, Scheibenbogen C, Keilholz U. Ghadjar P, et al. Among authors: scheibenbogen c. J Cancer Res Clin Oncol. 2008 Nov;134(11):1181-9. doi: 10.1007/s00432-008-0403-5. Epub 2008 May 9. J Cancer Res Clin Oncol. 2008. PMID: 18465142

2

The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75).

Scheibenbogen C, Keilholz U, Richter M, Andreesen R, Hunstein W. Scheibenbogen C, et al. Res Immunol. 1992 Jan;143(1):33-7. doi: 10.1016/0923-2494(92)80077-x. Res Immunol. 1992. PMID: 1565844

3

Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma.

Keilholz U, Scheibenbogen C, Brossart P, Möhler T, Tilgen W, Hunstein W. Keilholz U, et al. Among authors: scheibenbogen c. Recent Results Cancer Res. 1995;139:383-90. doi: 10.1007/978-3-642-78771-3_29. Recent Results Cancer Res. 1995. PMID: 7597305 Clinical Trial.

4

Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapy.

Möhler T, Willhauck M, Scheibenbogen C, Pawlita M, Bludau H, Brossart P, Hunstein W, Keilholz U. Möhler T, et al. Among authors: scheibenbogen c. Melanoma Res. 1995 Apr;5(2):129-32. doi: 10.1097/00008390-199504000-00010. Melanoma Res. 1995. PMID: 7620341

5

Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load.

Scheibenbogen C, Möhler T, Haefele J, Hunstein W, Keilholz U. Scheibenbogen C, et al. Melanoma Res. 1995 Jun;5(3):179-81. doi: 10.1097/00008390-199506000-00006. Melanoma Res. 1995. PMID: 7640519

6

A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood.

Brossart P, Schmier JW, Krüger S, Willhauck M, Scheibenbogen C, Möhler T, Keilholz U. Brossart P, et al. Among authors: scheibenbogen c. Cancer Res. 1995 Sep 15;55(18):4065-8. Cancer Res. 1995. PMID: 7664281

7

Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines.

Scheibenbogen C, Keilholz U, Meuer S, Dengler T, Tilgen W, Hunstein W. Scheibenbogen C, et al. Int J Cancer. 1993 May 28;54(3):494-8. doi: 10.1002/ijc.2910540323. Int J Cancer. 1993. PMID: 7685328

8

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).

Scheibenbogen C, Keilholz U, Mytilineos J, Suciu S, Manasterski M, Hunstein W. Scheibenbogen C, et al. Melanoma Res. 1994 Jun;4(3):191-4. doi: 10.1097/00008390-199406000-00008. Melanoma Res. 1994. PMID: 7919965 Clinical Trial.

9

Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions.

Keilholz U, Scheibenbogen C, Stoelben E, Saeger HD, Hunstein W. Keilholz U, et al. Among authors: scheibenbogen c. Eur J Cancer. 1994;30A(7):955-8. doi: 10.1016/0959-8049(94)90122-8. Eur J Cancer. 1994. PMID: 7946591

10

Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy.

Brossart P, Keilholz U, Scheibenbogen C, Möhler T, Willhauck M, Hunstein W. Brossart P, et al. Among authors: scheibenbogen c. J Immunother Emphasis Tumor Immunol. 1994 Jan;15(1):38-41. doi: 10.1097/00002371-199401000-00005. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8110729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters